M. Deraco

发表

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

E. Giovannetti, N. Funel, T. Lagerweij, 2018, EBioMedicine.

The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database *

T. Chua, D. Morris, P. Piso, 2011, Cancer.

Importance of gender in diffuse malignant peritoneal mesothelioma.

T. Chua, D. Morris, P. Piso, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Peritoneal Carcinomatosis: Feature of Dissemination a Review

N. Santoro, M. Deraco, M. Inglese, 1999, Tumori.

Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma

M. Daidone, N. Zaffaroni, M. Pennati, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma

S. Pilotti, S. Stacchiotti, F. Perrone, 2019, Modern Pathology.

Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.

M. Valenti, G. Fiorentini, F. Russo, 2001, Archives of surgery.

Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791).

L. Battaglia, M. Deraco, S. Kusamura, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.

M. Simone, A. Nissan, M. Pocard, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?

L. Battaglia, M. Deraco, S. Kusamura, 2021, Annals of Surgical Oncology.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

S. Bonomi, M. Milione, E. Leo, 2016, Annals of Surgical Oncology.

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

P. Faviana, M. Vaira, P. Sammartino, 2021, Annals of Surgical Oncology.

Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis

S. Mocellin, A. Gronchi, M. Lise, 2004, Cancer.

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

D. Morris, P. Piso, I. de Hingh, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.

F. Pietrantonio, M. Deraco, S. Kusamura, 2016, Critical reviews in oncology/hematology.

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

N. Zaffaroni, M. Pennati, C. De Marco, 2016, Journal of Translational Medicine.

The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, D. Baratti, 2013, Annals of Surgical Oncology.

Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

M. Daidone, R. Reddel, N. Zaffaroni, 2008, Clinical Cancer Research.

Multiple Mechanisms of TelomereMaintenance Exist and DifferentiallyAffect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

M. Daidone, R. Reddel, N. Zaffaroni, 2008 .

Advances in clinical research and management of diffuse peritoneal mesothelioma.

N. Zaffaroni, M. Deraco, S. Kusamura, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.

F. Valenza, M. Deraco, S. Kusamura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Current management strategies for peritoneal mesothelioma

H. Alexander, M. Deraco, K. Turaga, 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.

H. Alexander, P. Sugarbaker, M. Hesdorffer, 2016, Journal of oncology practice.

Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, A. Cabras, 2008, In vivo.

Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution

C. Mussi, L. Mariani, P. Casali, 2007, Annals of Surgical Oncology.

Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer

R. Bristow, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

A. Scivales, M. Deraco, S. Kusamura, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CDX‐2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases

P. Casali, D. Nonaka, M. Deraco, 2006, Histopathology.

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

M. Pierotti, S. Pilotti, F. Perrone, 2010, European journal of cancer.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi‐institutional experience

M. Pocard, D. Morris, P. Piso, 2018, Journal of surgical oncology.

Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic features.

M. Vaira, C. Rossi, M. Deraco, 2003, Journal of experimental & clinical cancer research : CR.

The American Society of Peritoneal Surface Malignancies Multi‐Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score

Lynette M. Smith, J. Esquivel, E. Levine, 2016, Journal of surgical oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

M. Solazzo, S. Bonomi, M. Deraco, 2011, Gynecologic oncology.

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

P. Ravenda, M. Deraco, S. Kusamura, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Regional Therapy in Ovarian Cancer

M. Deraco, S. Kusamura, F. Raspagliesi, 2007 .

Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases

F. Perrone, M. Milione, F. Pietrantonio, 2020, Annals of Surgical Oncology.

1st Evidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer

P. Delrio, S. Pignata, F. Roviello, 2017, Tumori.

Cytoreductive Surgery and HIPEC in the First-Line and Interval Time Points of Advanced Epithelial Ovarian Cancer

M. Deraco, S. Kusamura, D. Baratti, 2017, Indian Journal of Gynecologic Oncology.

Cytoreductive Surgery Followed by Intraperitoneal Hyperthermic Perfusion in the Treatment of Recurrent Epithelial Ovarian Cancer: A Phase II Clinical Study

N. Santoro, C. Rossi, M. Deraco, 2001, Tumori.

Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.

D. Giannarelli, C. Rossi, M. Santinami, 2003, Journal of experimental & clinical cancer research : CR.

The Role of CRS and HIPEC in the Management of Diffuse Malignant Peritoneal Mesothelioma (DMPM)

P. Garg, B. Rau, M. Sinn, 2021 .

Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds

E. Giovannetti, A. Avan, N. Funel, 2020, British Journal of Cancer.

Peritoneal Mesothelioma: Diagnosis and Management

M. Deraco, S. Kusamura, A. Cabras, 2019, Mesothelioma.

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types

T. Negri, S. Pilotti, S. Stacchiotti, 2018, Journal of immunology research.

Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).

I. Sperduti, C. Rossi, V. Ferraresi, 2009, In vivo.

Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2022, Annals of Surgical Oncology.

Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes.

M. Deraco, S. Kusamura, D. Baratti, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment of Recurrent Sarcoma of the Extremities by Isolated Limb Perfusion Using Tumor Necrosis Factor Alpha and Melphalan

A. Chiti, N. Santoro, A. Azzarelli, 1996, Tumori.

Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Milione, M. Deraco, S. Kusamura, 2018, Annals of Surgical Oncology.

Technical aspects of cytoreductive surgery

S. O'dwyer, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4–6, 2006): methodology of disease‐specific consensus

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC

M. Deraco, D. Baratti, 2022, Annals of Surgical Oncology.

Toward the molecular dissection of peritoneal pseudomyxoma.

F. D. De Braud, F. Perrone, A. Busico, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).

B. Rau, D. Morris, P. Piso, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)

M. Deraco, S. Kusamura, D. Baratti, 2019, Annals of Surgical Oncology.

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

T. Chua, J. Pelz, J. Esquivel, 2014, Journal of surgical oncology.

Management and complete resection of peritoneal and bone metastases from mucinous rectal carcinoma

L. Battaglia, M. Deraco, M. Cosimelli, 2020, Tumori.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

B. Rau, S. Ahrendt, M. Pocard, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

AIOM recommendations on the use of cytoreductive surgery and HIPEC in primary and secondary peritoneal tumors

A. Fagotti, D. Bellini, M. Deraco, 2021, Annals of Research in Oncology.

Peritoneal Mesothelioma: Disease Biology and Patterns of Peritoneal Dissemination

F. Perrone, N. Zaffaroni, M. Deraco, 2020 .

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of Surgical Oncology.

Mesothelioma

M. Deraco, 2021, Cancers.

Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.

D. Morelli, M. Deraco, S. Kusamura, 2018, European Journal of Surgical Oncology.

In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

M. Deraco, S. Kusamura, A. Cabras, 2010, Annals of Surgical Oncology.

Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.

A. Varrone, G. Fiorentini, G. Amicucci, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Modalities of Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, D. Baratti, Kusamura Shigeki, 2008, Annals of Surgical Oncology.

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis

S. Mocellin, M. Lise, P. Palatini, 2002, Cancer.

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.

M. Deraco, S. Kusamura, D. Baratti, 2014, The Lancet. Oncology.

Multi‐institutional experience of diffuse intra‐abdominal multicystic peritoneal mesothelioma

T. Chua, P. Sugarbaker, B. Moran, 2011, The British journal of surgery.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

M. Vaira, M. Deraco, S. Kusamura, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

D. Nonaka, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy.

M. Deraco, S. Kusamura, D. Baratti, 2015, International journal of surgery.

The nanomechanical fingerprint of colorectal-derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

S. Bonomi, M. Deraco, S. Kusamura, 2013, Journal of surgical oncology.

Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)

B. Moran, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

S. Andreola, D. Nonaka, M. Deraco, 2008, Annals of Surgical Oncology.

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.

M. Simone, A. Nissan, B. Rau, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes

M. Milione, F. Morano, F. Pietrantonio, 2022, Annals of Surgical Oncology.

Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study

M. Milione, F. Pietrantonio, M. Deraco, 2016, Annals of Surgical Oncology.

Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, D. Baratti, 2012, Annals of surgery.

Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series

M. Milione, L. Battaglia, F. Pietrantonio, 2018, Annals of Surgical Oncology.

Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series

M. Milione, L. Battaglia, F. Pietrantonio, 2017, Annals of Surgical Oncology.

Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study

D. Morris, P. Piso, E. Levine, 2016, Annals of surgery.

Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

T. Chua, D. Morris, D. Elias, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Vaira, P. Sammartino, P. Del Bianco, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2022, Annals of Surgical Oncology.

Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2018, Annals of Surgical Oncology.

A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.

D. Morris, P. Piso, D. Elias, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.

M. Lise, M. Foletto, D. Giannarelli, 1999, Journal of immunotherapy.

The consensus statement on the locoregional treatment of abdominal sarcomatosis

P. Casali, C. Rossi, M. Deraco, 2008, Journal of surgical oncology.

Stop Flow in abdominal and pelvic cancer relapses.

F. Fiore, S. Pignata, B. Daniele, 2006, Frontiers in bioscience : a journal and virtual library.

Chemotherapy of peritoneal disseminations of colorectal origin

M. Deraco, S. Kusamura, D. Baratti, 2014 .

Circulating CA125 and diffuse malignant peritoneal mesothelioma.

M. Deraco, S. Kusamura, D. Baratti, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies

M. Deraco, S. Kusamura, D. Baratti, 2009, Journal of surgical oncology.

Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemic

L. Battaglia, M. Deraco, S. Kusamura, 2022, Updates in Surgery.

Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience.

M. Deraco, S. Kusamura, D. Baratti, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases

S. Bonomi, M. Deraco, S. Kusamura, 2013, Tumori.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.

S. Bonomi, M. Deraco, S. Kusamura, 2013, Tumori.

The nanomechanical fingerprint of colorectal cancer-derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis

M. Vaira, I. Sperduti, P. Sammartino, 2022, Cancers.

Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity

F. Grosso, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

N-Nitroso compounds, bacteria, and carcinoembryonic antigen in the gastric stump.

P. I. Reed, M. Valenti, M. Deraco, 1998, The Journal of surgical research.

Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

M. Deraco, S. Kusamura, D. Baratti, 2010, World journal of gastrointestinal oncology.

Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, R. Younan, 2007, Annals of Surgical Oncology.

Morbidity and quality of life following cytoreduction and HIPEC.

M. Deraco, S. Kusamura, D. Baratti, 2007, Cancer treatment and research.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

T. Chua, D. Morris, P. Piso, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

J. Esquivel, D. Elias, M. Deraco, 2008, Journal of surgical oncology.

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

G. Pelosi, F. D. De Braud, F. Perrone, 2014, The oncologist.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

T. Chua, J. Pelz, D. Morris, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decellularized Normal and Tumor Extracellular Matrix as Scaffold for Cancer Organoid Cultures of Colorectal Peritoneal Metastases

M. Gariboldi, G. Pruneri, M. Pierotti, 2021, bioRxiv.

Experience with peritoneal mesothelioma at the Milan National Cancer Institute.

S. Pilotti, F. Perrone, N. Zaffaroni, 2010, World journal of gastrointestinal oncology.

Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

P. Dileo, M. Deraco, S. Kusamura, 2009, Annals of Surgical Oncology.

Diffuse malignant mesothelioma of the peritoneum

P. Casali, J. Rosai, D. Nonaka, 2005, Cancer.

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

E. Seregni, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

P. Casali, J. Rosai, D. Nonaka, 2006, Annals of Surgical Oncology.

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion

P. Casali, R. Bertulli, M. Deraco, 2003, Journal of surgical oncology.

Intraperitoneal Hyperthermic Chemotherapy in Gastric Cancer: Rationale for a new Approach

F. Bozzetti, M. Deraco, M. Vaglini, 1998, Tumori.

Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework

P. Casali, T. Negri, S. Pilotti, 2016, Oncotarget.

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

N. Zaffaroni, M. Pennati, M. de Cesare, 2015, Oncotarget.

Pathophysiology and biology of peritoneal carcinomatosis.

N. Zaffaroni, R. Villa, M. Deraco, 2010, World journal of gastrointestinal oncology.

A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer

F. Masedu, G. Fiorentini, G. Scambia, 2020, International journal of molecular sciences.

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

T. Chua, J. Pelz, J. Esquivel, 2014, Annals of Surgical Oncology.

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry.

J. Tuech, M. Deraco, S. Kusamura, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy.

M. Deraco, S. Kusamura, A. Cabras, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

N. Zaffaroni, M. Pennati, V. Zuco, 2017, Journal of Hematology & Oncology.

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.

F. D. De Braud, M. Milione, F. Morano, 2019, Clinical colorectal cancer.

Fertility preservation in women with peritoneal surface malignancies: A case series.

M. Deraco, S. Kusamura, E. Somigliana, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei

S. Andreola, M. Deraco, S. Kusamura, 2004, Annals of Surgical Oncology.

Pharmacokinetics of Mitomycin C in Pelvic Stopflow Infusion and Hypoxic Pelvic Perfusion with and without Hemofiltration: A Pilot Study of Patients with Recurrent Unresectable Rectal Cancer

K. Aigner, M. Deraco, S. Guadagni, 1998, Journal of clinical pharmacology.

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

M. Dugo, N. Zaffaroni, G. Colella, 2022, Cancer Gene Therapy.

Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research

M. Deraco, S. Kusamura, D. Baratti, 2011, Journal of surgical oncology.

Management of peritoneal surface component of ovarian cancer.

M. Deraco, S. Kusamura, F. Raspagliesi, 2003, Surgical oncology clinics of North America.

The eligibility for local‐regional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusion

E. Cotte, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion

M. Deraco, S. Kusamura, R. Younan, 2006, Cancer.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2011, Annals of Surgical Oncology.

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

F. Kwiatkowski, D. Elias, E. Levine, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.

M. Deraco, S. Kusamura, D. Baratti, 2003, Journal of experimental & clinical cancer research : CR.

Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion

M. Deraco, S. Kusamura, R. Younan, 2005, Annals of Surgical Oncology.

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

J. Pelz, D. Morris, P. Piso, 2021, JAMA surgery.

Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry

M. Simone, K. Chouliaras, D. Morris, 2018, Annals of Surgical Oncology.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’

F. Roviello, D. Marrelli, L. Marano, 2021, Annals of Surgical Oncology.

Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.

F. Masedu, G. Fiorentini, E. Ricevuto, 2019, Minerva chirurgica.

Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study

F. Masedu, G. Fiorentini, E. Ricevuto, 2018, Updates in Surgery.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience

M. Pocard, D. Morris, P. Piso, 2018, Annals of Surgical Oncology.

American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer

J. Pelz, J. Esquivel, P. Piso, 2014, Journal of surgical oncology.

Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)

F. Roviello, G. Fiorentini, L. Ansaloni, 2023, Cancers.

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

L. Mariani, F. Perrone, A. Gloghini, 2016, Journal of Translational Medicine.

Circulating tumor markers: Predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei

M. Deraco, S. Kusamura, D. Baratti, 2013, Journal of surgical oncology.

Pseudomyxoma Peritonei: Biological Features Are the Dominant Prognostic Determinants After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

D. Nonaka, M. Deraco, S. Kusamura, 2009, Annals of surgery.

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma

A. Gronchi, M. Deraco, S. Kusamura, 2015, Journal of surgical oncology.

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

M. Fiore, M. Deraco, S. Kusamura, 2010, Annals of Surgical Oncology.

Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

G. Salti, P. Sugarbaker, P. Sammartino, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes

M. Milione, F. Morano, F. Pietrantonio, 2022, Annals of Surgical Oncology.

Force Sensing on Cells and Tissues by Atomic Force Microscopy

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study

M. Valenti, G. Fiorentini, G. Amicucci, 2003, Melanoma research.

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study

M. Valenti, F. Masedu, G. Fiorentini, 2017, Melanoma research.

Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.

M. Valenti, G. Fiorentini, F. Russo, 2002, American journal of surgery.

Isolated Pelvic Perfusion for the Treatment of Unresectable Primary or Recurrent Rectal Cancer

A. Chiti, M. Santinami, M. Deraco, 1996, Tumori.

Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences.

R. Cavaliere, M. Santinami, M. Deraco, 1994, Melanoma research.

Regional perfusion in the treatment of locally advanced pelvic cancer

N. Cascinelli, N. Santoro, M. Santinami, 1994 .

Peritoneal Mesothelioma: Systematic Review of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocol Outcomes

O. Sgarbura, M. Deraco, S. Kusamura, 2023, Indian Journal of Surgical Oncology.

Stop Flow in Abdominal and Pelvic Relapses. Phase I Study and Phase Ii Preliminary. Sitilo National Project Data

F. Fiore, S. Pignata, B. Memoli, 2002 .

Consensus statement on peritoneal mesothelioma

D. Bartlett, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.

M. Simone, A. Nissan, J. Burger, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

M. Deraco, S. Kusamura, A. Cabras, 2016, Annals of Surgical Oncology.

Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

R. Bertulli, M. Deraco, S. Kusamura, 2013, European journal of cancer.

Locoregional treatment of peritoneal carcinomatosis from gastric cancer

Wiley Interscience, F. Bozzetti, M. Deraco, 2008, Journal of surgical oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of surgical oncology.

Lymph Node Metastases in Diffuse Malignant Peritoneal Mesothelioma

M. Deraco, S. Kusamura, A. Cabras, 2009, Annals of Surgical Oncology.

HIPEC Methodology and Regimens: The Need for an Expert Consensus

I. de Hingh, M. Deraco, S. Kusamura, 2021, Annals of Surgical Oncology.

[Pseudo-continent perineal colostomies after amputation of the rectum for cancer].

P. Rougier, D. Elias, P. Lasser, 1993, Gastroenterologie clinique et biologique.

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.

F. Guadagni, D. Giannarelli, M. Vaira, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.

M. Vaira, C. Rossi, M. Deraco, 2003, Journal of experimental & clinical cancer research : CR.

F. Guadagni, D. Giannarelli, M. Vaira, 2022 .

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi‐institutional study

M. Solazzo, S. Bonomi, M. Deraco, 2012, BJOG : an international journal of obstetrics and gynaecology.

Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.

S. Cascinu, L. Ansaloni, R. Cirocchi, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?

V. Mazzaferro, L. Battaglia, M. Deraco, 2018, Diseases of the colon and rectum.

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei

D. Morris, D. Elias, E. Levine, 2014, The British journal of surgery.

Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies

M. Deraco, S. Kusamura, D. Baratti, 2012, Annals of surgery.

Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.

A. Facciorusso, M. Deraco, S. Kusamura, 2021, European Journal of Surgical Oncology.

120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study.

D. Giannarelli, M. Vaira, C. Rossi, 2006, In vivo.

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study

K. Campbell, A. Nissan, D. Morris, 2021, BMJ Open.

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study(PRECINCT- Patterns of peritoneal dissemination and REsponse to Chemotherapy IN patients

K. Campbell, A. Nissan, D. Morris, 2021, medRxiv.

Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers.

L. Battaglia, M. Deraco, S. Kusamura, 2018, Surgical oncology clinics of North America.

Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

E. Seregni, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Clinical Pathway for Peritoneal Carcinomatosis from Colon and Rectal Cancer: Guidelines for Current Practice

P. Sugarbaker, M. Deraco, A. G. Portilla, 1997, Tumori.

Feasibility of Peritonectomy Associated with Intraperitoneal Hyperthermic Perfusion in Patients with Pseudomyxoma Peritonei

V. Mazzaferro, A. Gronchi, M. Deraco, 2002, Tumori.

Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale.

S. Laurberg, J. Esquivel, D. Morris, 2012, Tumori.

Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer: a Two-Center Study of 101 Patients

S. Bonomi, E. Leo, M. Deraco, 2014, Diseases of the colon and rectum.

Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study

M. Deraco, S. Kusamura, A. Cabras, 2012, Annals of Surgical Oncology.

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma

D. Marrelli, L. Ansaloni, M. Deraco, 2023, Cancers.

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer: A Multi-Institutional Study

M. Solazzo, S. Bonomi, M. Deraco, 2013 .

How can cytoreductive surgery (CRS) and hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) be implemented in ovarian cancer therapy in Poland? - A report from the 1st Kujawsko-Pomorski days of cytoreductive surgery

W. Zegarski, M. Deraco, M. Bidziński, 2013 .

Biological Features Are the Dominant Prognostic Determinants After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

D. Nonaka, M. Deraco, S. Kusamura, 2009 .

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

M. Deraco, S. Kusamura, A. Cabras, 2015, Annals of Surgical Oncology.

The nanomechanical fingerprint of colorectal cancer -derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Peritoneal Mesothelioma and HIV Infection

F. Crippa, M. Deraco, S. Kusamura, 2010 .

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in a patient with peritoneal mesothelioma and HIV infection.

F. Crippa, M. Deraco, S. Kusamura, 2010, Tumori.

The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs.

M. Deraco, S. Kusamura, P. Rossi, 2012, Surgical oncology clinics of North America.

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

P. Casali, N. Zaffaroni, M. Deraco, 2003, Tumori.

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.

L. Mariani, M. Deraco, S. Kusamura, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma

S. Pilotti, F. Perrone, A. Belfiore, 2019, International journal of molecular sciences.

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

S. Bonomi, D. Morelli, M. Deraco, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases

M. Gariboldi, G. Pruneri, M. Pierotti, 2022, Journal of molecular cell biology.

[Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology].

M. Vaira, C. Rossi, M. Deraco, 2003, Tumori.

Phase II randomized study on tissue distribution of cisplatin according to different levels of intra abdominal pressure during HIPEC: Preliminary results. NCT02949791

M. Deraco, S. Kusamura, G. Garrone, 2018, European Journal of Surgical Oncology.

HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY WITH CYTOREDUCTIVE SURGERY FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS FROM COLORECTAL ORGIN

M. Deraco, I. Huțanu, B. Filip, 2013 .

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.

O. Sgarbura, V. Boige, K. Flatmark, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Correlation between biological and mechanical properties of extracellular matrix from colorectal peritoneal metastases in human tissues

M. Gariboldi, A. Podestà, M. Deraco, 2023, Scientific reports.

2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma

O. Sgarbura, M. Deraco, S. Kusamura, 2023, Annals of Surgical Oncology.

Colobronchial fistula: an unusual complication after peritonectomy and hyperthermic intra-peritoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2009, In vivo.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

M. Vaira, M. Deraco, S. Kusamura, 2010 .

Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.

M. Deraco, S. Kusamura, D. Baratti, 2009, In vivo.

Uterine Sarcoma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion: a Feasiblity Study

P. Casali, A. Gronchi, M. Deraco, 2004, Journal of chemotherapy.

Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin.

A. Accorsi, G. La Manna, S. Bonomi, 2006, In Vivo.

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

N. Zaffaroni, M. Pennati, C. De Marco, 2016, Journal of Translational Medicine.

Mytomicin-C, metronomic capecitabine and bevacizumab in patients with unresectable or relapsed Pseudomyxoma Peritonei of appendiceal origin

M. Milione, M. Nannini, F. Morano, 2023, Clinical Colorectal Cancer.

Current management strategies for peritoneal mesothelioma

M. Deraco, K. Turaga, Richard Alexander, 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

P. Piso, J. Spiliotis, P. Sugarbaker, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prevention and early treatment of peritoneal metastases from colorectal cancer: Second‐look laparotomy or prophylactic HIPEC?

M. Deraco, S. Kusamura, D. Baratti, 2014, Journal of surgical oncology.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience

M. Pocard, D. Morris, P. Piso, 2018, Annals of Surgical Oncology.

A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database *

T. Chua, D. Morris, P. Piso, 2011, Cancer.

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

A. Scivales, M. Deraco, D. Baratti, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.

D. Morelli, M. Deraco, S. Kusamura, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.

M. Deraco, S. Kusamura, D. Baratti, 2006, In vivo.

Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis

P. Faviana, M. Vaira, P. Sammartino, 2023, Annals of Surgical Oncology.

Reply to M. Markman

D. Morris, P. Piso, D. Elias, 2010 .

Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.